Amgen (AMGN) PT Raised to $372 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Evan David Seigerman raised the price target on Amgen (NASDAQ: AMGN) to $372.00 (from $335.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
